Rachel J. Cook, M.D., M.S.

Rachel J. Cook, M.D., M.S., is an Associate Professor of Medicine at Oregon Health & Science University. Her research focuses on hematological malignancies, specifically acute myeloid leukemia (AML), myeloid neoplasia, and stem cell transplantation. She specializes in optimizing post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis for mismatched unrelated donor transplants and developing novel combination therapies for relapsed/refractory AML, including ruxolitinib, venetoclax, and CDK9 inhibitors. Her recent work includes the GEN-PHEN-VEN study correlating genetic and phenotypic factors with venetoclax outcomes and the PRISM prognostic model for newly diagnosed AML. Her findings have been published in Blood, Journal of Clinical Oncology, and Blood Cancer Discovery.